FdaApplication
NDA 020114
Identifiers
- fda_app_no: NDA020114
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | NDA |
| approval_date | 1996-11-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ASTELIN | AZELASTINE HYDROCHLORIDE | 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED;NASAL |
1 product